시장보고서
상품코드
1110434

심막 패치 시장(제품 유형별 : 자가 이식, 이종이식, 합성/애플리케이션별 : 심장혈관 외과, 치과 외과, 안과, 기타) : 세계 산업 분석, 규모, 점유율, 성장률, 동향, 예측(2022-2031년)

Pericardial Patches Market (Product Type: Autologous, Xenograft, and Synthetic; and Application: Cardiovascular Surgery, Dental Surgery, Ophthalmology, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 176 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 심막 패치 시장에 대해 조사분석했으며, 시장 개요, 시장 분석, 경쟁 구도 등의 정보를 정리하여 전해드립니다.

목차

제1장 서문

제2장 전제와 조사 방법

제3장 개요 : 세계의 심막 패치 시장

제4장 시장 개요

  • 서론
    • 부문의 정의
    • 업계의 진화/발전
  • 개요
  • 시장 역학
    • 촉진요인
    • 억제요인
    • 기회
  • 세계의 심막 패치 시장 분석과 예측(2017-2031년)
    • 시장 매출 예측(100만 달러)

제5장 주요 인사이트

  • 심막 패치 시장의 개요
  • 기술의 진보
  • 주요 업계 이벤트(합병, 인수, 파트너십 등)
  • COVID-19 팬데믹의 산업에 대한 영향(밸류체인과 단기·중기·장기 영향)

제6장 세계의 심막 패치 시장 분석과 예측 : 제품 유형별

  • 서론과 정의
  • 주요 조사 결과/개발
  • 시장 금액 예측(2017-2031년) : 제품 유형별
    • 자가 이식
    • 이종이식
    • 합성
  • 시장의 매력 분석 : 제품 유형별

제7장 세계의 심막 패치 시장 분석과 예측 : 애플리케이션별

  • 서론과 정의
  • 주요 조사 결과/개발
  • 시장 금액 예측(2017-2031년) : 애플리케이션별
    • 심장혈관 외과
    • 치과 외과
    • 안과
    • 기타
  • 시장의 매력 분석 : 애플리케이션별

제8장 세계의 심막 패치 시장 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 조사 결과/개발
  • 시장 금액 예측(2017-2031년) : 최종사용자별
    • 병원
    • 외래 수술 센터
    • 기타
  • 시장의 매력 분석 : 최종사용자별

제9장 세계의 심막 패치 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 시장 금액 예측 : 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동·아프리카
  • 시장의 매력 분석 : 지역별

제10장 북미의 심막 패치 시장 분석과 예측

제11장 유럽의 심막 패치 시장 분석과 예측

제12장 아시아태평양의 심막 패치 시장 분석과 예측

제13장 라틴아메리카의 심막 패치 시장 분석과 예측

제14장 중동 및 아프리카의 심막 패치 시장 분석과 예측

제15장 경쟁 구도

  • 시장 참여 기업 - 경쟁 매트릭스(층 및 기업 규모별)
  • 기업 개요
    • Edwards Lifesciences Corporation
    • Abbott
    • Baxter International
    • Visionary medtech solutions
    • CryoLife, Inc.
    • LeMaitre Vascular, Inc.
    • Neovasc Inc.
    • FOC Medical
    • WL Gore &Associates, Inc.
    • Collagen Solutions Plc
KSA 22.08.18

The report provides revenue of the global pericardial patches market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pericardial patches market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pericardial patches market.

The report delves into the competitive landscape of the global pericardial patches market. Key players operating in the global pericardial patches market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global pericardial patches market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pericardial Patches Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Pericardial Patches Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Overview of Pericardial Patches Market
  • 5.2. Technology advancements
  • 5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Pericardial Patches Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Autologous
    • 6.3.2. Xenograft
      • 6.3.2.1. Bovine
      • 6.3.2.2. Porcine
      • 6.3.2.3. Equine
    • 6.3.3. Synthetic
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Pericardial Patches Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Cardiovascular Surgery
    • 7.3.2. Dental Surgery
    • 7.3.3. Ophthalmology
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Pericardial Patches Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Pericardial Patches Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Pericardial Patches Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Autologous
    • 10.2.2. Xenograft
      • 10.2.2.1. Bovine
      • 10.2.2.2. Porcine
      • 10.2.2.3. Equine
    • 10.2.3. Synthetic
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Cardiovascular Surgery
    • 10.3.2. Dental Surgery
    • 10.3.3. Ophthalmology
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Ambulatory Surgical Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Pericardial Patches Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Autologous
    • 11.2.2. Xenograft
      • 11.2.2.1. Bovine
      • 11.2.2.2. Porcine
      • 11.2.2.3. Equine
    • 11.2.3. Synthetic
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Cardiovascular Surgery
    • 11.3.2. Dental Surgery
    • 11.3.3. Ophthalmology
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Ambulatory Surgical Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-Region

12. Asia Pacific Pericardial Patches Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Autologous
    • 12.2.2. Xenograft
      • 12.2.2.1. Bovine
      • 12.2.2.2. Porcine
      • 12.2.2.3. Equine
    • 12.2.3. Synthetic
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Cardiovascular Surgery
    • 12.3.2. Dental Surgery
    • 12.3.3. Ophthalmology
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Ambulatory Surgical Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-Region

13. Latin America Pericardial Patches Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Autologous
    • 13.2.2. Xenograft
      • 13.2.2.1. Bovine
      • 13.2.2.2. Porcine
      • 13.2.2.3. Equine
    • 13.2.3. Synthetic
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Cardiovascular Surgery
    • 13.3.2. Dental Surgery
    • 13.3.3. Ophthalmology
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Ambulatory Surgical Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-Region

14. Middle East & Africa Pericardial Patches Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Autologous
    • 14.2.2. Xenograft
      • 14.2.2.1. Bovine
      • 14.2.2.2. Porcine
      • 14.2.2.3. Equine
    • 14.2.3. Synthetic
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Cardiovascular Surgery
    • 14.3.2. Dental Surgery
    • 14.3.3. Ophthalmology
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Ambulatory Surgical Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-Region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Edwards Lifesciences Corporation
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Product Portfolio
      • 15.2.1.3. Financial Overview
      • 15.2.1.4. SWOT Analysis
      • 15.2.1.5. Strategic Overview
    • 15.2.2. Abbott
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Product Portfolio
      • 15.2.2.3. Financial Overview
      • 15.2.2.4. SWOT Analysis
      • 15.2.2.5. Strategic Overview
    • 15.2.3. Baxter International
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Product Portfolio
      • 15.2.3.3. Financial Overview
      • 15.2.3.4. SWOT Analysis
      • 15.2.3.5. Strategic Overview
    • 15.2.4. Visionary medtech solutions
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Product Portfolio
      • 15.2.4.3. Financial Overview
      • 15.2.4.4. SWOT Analysis
      • 15.2.4.5. Strategic Overview
    • 15.2.5. CryoLife, Inc.
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Product Portfolio
      • 15.2.5.3. Financial Overview
      • 15.2.5.4. SWOT Analysis
      • 15.2.5.5. Strategic Overview
    • 15.2.6. LeMaitre Vascular, Inc.
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Product Portfolio
      • 15.2.6.3. Financial Overview
      • 15.2.6.4. SWOT Analysis
      • 15.2.6.5. Strategic Overview
    • 15.2.7. Neovasc Inc.
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Product Portfolio
      • 15.2.7.3. Financial Overview
      • 15.2.7.4. SWOT Analysis
      • 15.2.7.5. Strategic Overview
    • 15.2.8. FOC Medical
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Product Portfolio
      • 15.2.8.3. Financial Overview
      • 15.2.8.4. SWOT Analysis
      • 15.2.8.5. Strategic Overview
    • 15.2.9. W. L. Gore & Associates, Inc.
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Product Portfolio
      • 15.2.9.3. Financial Overview
      • 15.2.9.4. SWOT Analysis
      • 15.2.9.5. Strategic Overview
    • 15.2.10. Collagen Solutions Plc
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Product Portfolio
      • 15.2.10.3. Financial Overview
      • 15.2.10.4. SWOT Analysis
      • 15.2.10.5. Strategic Overvie
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제